The Humana Effect: A Cautionary Tale of Wall Street's Blind Spots Humana's stock performance has been remarkable, outpacing both the broader market and its peers in the healthcare sector. With a 30.
8% gain over the past year, the company's market cap now stands at $36. 6 billion. However, this impressive rise may mask underlying issues.
Wall Street's Earnings Enchantment Humana's Q1 results, released on April 29, showed adjusted earnings per share (EPS) of $10. 31, surpassing expectations by a wide margin.